Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens

• Published in: Antimicrobial Agents and Chemotherapy 2014-01, Vol.58 (1), p.128-135
• Main Authors: MINCES, Lucio R, HONG NGUYEN, M, BHAMA, Jay K, TOYODA, Yoshiya, CLANCY, Cornelius J, MITSANI, Dimitra, SHIELDS, Ryan K, KWAK, Eun J, SILVEIRA, Fernanda P, ABDEL-MASSIH, Rima, PILEWSKI, Joseph M, CRESPO, Maria M, BERMUDEZ, Christian
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral Agents; Antiviral Agents - therapeutic use; Biological and medical sciences; Cytomegalovirus Infections; Cytomegalovirus Infections - drug therapy; Drug Resistance, Viral; Drug Resistance, Viral - drug effects; Female; Foscarnet; Foscarnet - therapeutic use; Ganciclovir; Ganciclovir - therapeutic use; Humans; Infectious diseases; Lung Transplantation; Male; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Retrospective Studies; Viral diseases; Viremia - drug therapy; Young Adult
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.00561-13

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • [e-mail] Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC